Viela Bio is a clinical-stage biotechnology company advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the root cause of disease.
|Goldman Sachs, Temasek Holdings, Viking Global Investors, Boyu Capital, Hillhouse Capital Group, Cormorant Asset Management, Temasek, 6 Dimensions Capital, Sirona Capital, HBM Healthcare Investments, Barer & Son Capital, Terra Magnum Capital Partners|
Viela Bio has 184 Twitter Followers. The number of followers has decreased 1.8% month over month and decreased 2.2% quarter over quarter
When was Viela Bio founded?
Viela Bio was founded in 2018.
Who are Viela Bio key executives?
Viela Bio's key executives are Bing Yao, Mitchell Chan and Edward Hu.
How many employees does Viela Bio have?
Viela Bio has 95 employees.
What is Viela Bio revenue?
Latest Viela Bio annual revenue is $11.7 m.
What is Viela Bio revenue per employee?
Latest Viela Bio revenue per employee is $122.7 k.
Who are Viela Bio competitors?
Competitors of Viela Bio include BIA Separations, Conagen and Genomatica.
Where is Viela Bio headquarters?
Viela Bio headquarters is located at 1 Medimmune Way, Gaithersburg.
Where are Viela Bio offices?
Viela Bio has offices in Gaithersburg and Rockville.
How many offices does Viela Bio have?
Viela Bio has 2 offices.
Receive alerts for 300+ data fields across thousands of companies